Skip to main content

Antibiotics Topic Center

Featured Article

News
01/19/2023
Jolynn Tumolo
A prescription antibiotic used to treat tuberculosis is being recalled for failing to meet impurity/degradation specifications.
A prescription antibiotic used to treat tuberculosis is being recalled for failing to meet impurity/degradation specifications.
A prescription antibiotic used...
01/19/2023
Pharmacy Learning Network
News
12/21/2022
Arthur Allen; Liz Szabo
The PASTEUR Act, which would provide $6 billion to pharmaceutical manufacturers to incentivize antibiotic development, has sparked support and criticism throughout the health care industry.
The PASTEUR Act, which would provide $6 billion to pharmaceutical manufacturers to incentivize antibiotic development, has sparked support and criticism throughout the health care industry.
The PASTEUR Act, which would...
12/21/2022
Pharmacy Learning Network
News
12/08/2022
Edan Stanley
“The implementation of an antimicrobial stewardship monitoring program within the long-term care setting could assist in maximizing therapy while reducing antibiotic exposure,” found researchers.
“The implementation of an antimicrobial stewardship monitoring program within the long-term care setting could assist in maximizing therapy while reducing antibiotic exposure,” found researchers.
“The implementation of an...
12/08/2022
Veterans Health Today
From Veterans Health Today
Headshot and logo for Talking Therapeutics with Douglas Jennings, PharmD
Talking Therapeutics
09/22/2022
Douglas L. Jennings, PharmD, FACC, FAHA, FCCP, FHFSA, BCPS
Dr Jennings reviews guideline recommendations and new research into the use of antibiotics in patients who are about to undergo invasive dental procedures.
Dr Jennings reviews guideline recommendations and new research into the use of antibiotics in patients who are about to undergo invasive dental procedures.
Dr Jennings reviews guideline...
09/22/2022
Pharmacy Learning Network
News
02/26/2021
Ascend Laboratories is recalling nine lots of cephalexin for oral suspension because impurity results during testing were “at [the] higher side of the specification limit.”
Ascend Laboratories is recalling nine lots of cephalexin for oral suspension because impurity results during testing were “at [the] higher side of the specification limit.”
Ascend Laboratories is recalling...
02/26/2021
Pharmacy Learning Network
News
01/04/2021
A growing body of research shows that overuse and misuse of antibiotics in children’s hospitals is helping fuel superbugs, which typically strike frail older adults but are increasingly infecting kids—and the pandemic is making things worse.
A growing body of research shows that overuse and misuse of antibiotics in children’s hospitals is helping fuel superbugs, which typically strike frail older adults but are increasingly infecting kids—and the pandemic is making things worse.
A growing body of research shows...
01/04/2021
Pharmacy Learning Network
News
06/03/2020
A Class II recall is active for a prescription antibiotic used to treat bacterial infections.
A Class II recall is active for a prescription antibiotic used to treat bacterial infections.
A Class II recall is active for...
06/03/2020
Pharmacy Learning Network
News
03/27/2020
A prescription antibiotic used to treat a variety of bacterial infections, such as acne, urinary tract infections, and respiratory infections is being recalled.
A prescription antibiotic used to treat a variety of bacterial infections, such as acne, urinary tract infections, and respiratory infections is being recalled.
A prescription antibiotic used...
03/27/2020
Pharmacy Learning Network
News
02/21/2020
During the first trimester of pregnancy, researchers found macrolide antibiotics increase the risk of major malformations, specifically cardiovascular malformations, compared with those who received penicillin antibiotics.
During the first trimester of pregnancy, researchers found macrolide antibiotics increase the risk of major malformations, specifically cardiovascular malformations, compared with those who received penicillin antibiotics.
During the first trimester of...
02/21/2020
Pharmacy Learning Network
News
02/03/2020
Although guidelines recommend antibiotic prophylaxis before or during endoscopic ultrasound-guided fine needle aspiration of pancreatic cysts, the risk of infection from the procedure is low, a randomized controlled trial reveals.
Although guidelines recommend antibiotic prophylaxis before or during endoscopic ultrasound-guided fine needle aspiration of pancreatic cysts, the risk of infection from the procedure is low, a randomized controlled trial reveals.
Although guidelines recommend...
02/03/2020
Pharmacy Learning Network

Newsfeed

News
01/19/2023
Jolynn Tumolo
A prescription antibiotic used to treat tuberculosis is being recalled for failing to meet impurity/degradation specifications.
A prescription antibiotic used to treat tuberculosis is being recalled for failing to meet impurity/degradation specifications.
A prescription antibiotic used...
01/19/2023
Pharmacy Learning Network
News
12/21/2022
Arthur Allen; Liz Szabo
The PASTEUR Act, which would provide $6 billion to pharmaceutical manufacturers to incentivize antibiotic development, has sparked support and criticism throughout the health care industry.
The PASTEUR Act, which would provide $6 billion to pharmaceutical manufacturers to incentivize antibiotic development, has sparked support and criticism throughout the health care industry.
The PASTEUR Act, which would...
12/21/2022
Pharmacy Learning Network
News
12/08/2022
Edan Stanley
“The implementation of an antimicrobial stewardship monitoring program within the long-term care setting could assist in maximizing therapy while reducing antibiotic exposure,” found researchers.
“The implementation of an antimicrobial stewardship monitoring program within the long-term care setting could assist in maximizing therapy while reducing antibiotic exposure,” found researchers.
“The implementation of an...
12/08/2022
Veterans Health Today
News
10/22/2019
"A recent multicenter trial showed that antibiotic prescribing can be reduced safely in COPD patients by using a rapid diagnostic (C-reactive protein) test," study coauthor Laura Shallcross, PhD, University College London, explained.
"A recent multicenter trial showed that antibiotic prescribing can be reduced safely in COPD patients by using a rapid diagnostic (C-reactive protein) test," study coauthor Laura Shallcross, PhD, University College London, explained.
"A recent multicenter trial...
10/22/2019
Pharmacy Learning Network
News
05/01/2019
According to new study findings, each additional day of surgical antimicrobial prophylaxis increases the risks of acute kidney injury and Clostridium difficile infection and does not lead to reductions in surgical site infections.
According to new study findings, each additional day of surgical antimicrobial prophylaxis increases the risks of acute kidney injury and Clostridium difficile infection and does not lead to reductions in surgical site infections.
According to new study findings,...
05/01/2019
Pharmacy Learning Network
News
03/07/2019
Many antibiotic prescriptions for common infections in primary care exceed durations recommended by guidelines, according to a new study.
Many antibiotic prescriptions for common infections in primary care exceed durations recommended by guidelines, according to a new study.
Many antibiotic prescriptions...
03/07/2019
Pharmacy Learning Network
News
05/11/2018
A new study examined the risk of kidney stones in patients taking oral antibiotics. 
A new study examined the risk of kidney stones in patients taking oral antibiotics. 
A new study examined the risk...
05/11/2018
Pharmacy Learning Network
News
04/05/2018
The CDC identified over 200 cases of bacteria with rare antibiotic resistance genes in 27 states during the first 9 months of 2017, according to a new report.
The CDC identified over 200 cases of bacteria with rare antibiotic resistance genes in 27 states during the first 9 months of 2017, according to a new report.
The CDC identified over...
04/05/2018
Pharmacy Learning Network
News
03/05/2026
Grace Taylor, MS, MA
Rising Pharma has voluntarily recalled one nationwide lot of temozolomide 5 mg capsules after stability testing revealed out-of-specification impurities results.
Rising Pharma has voluntarily recalled one nationwide lot of temozolomide 5 mg capsules after stability testing revealed out-of-specification impurities results.
Rising Pharma has voluntarily...
03/05/2026
Pharmacy Learning Network
News
03/05/2026
Grace Taylor, MS, MA
HTO Nevada has voluntarily recalled more than 27 000 bottles of Five-Star Vasocaine Spray nationwide after determining that stability data do not support the product’s labeled expiration dates.
HTO Nevada has voluntarily recalled more than 27 000 bottles of Five-Star Vasocaine Spray nationwide after determining that stability data do not support the product’s labeled expiration dates.
HTO Nevada has voluntarily...
03/05/2026
Pharmacy Learning Network
News
03/05/2026
Grace Taylor, MS, MA
Mylan Pharmaceuticals has voluntarily recalled select lots of isotretinoin 40 mg capsules distributed nationwide after the product failed to meet dissolution specifications.
Mylan Pharmaceuticals has voluntarily recalled select lots of isotretinoin 40 mg capsules distributed nationwide after the product failed to meet dissolution specifications.
Mylan Pharmaceuticals has...
03/05/2026
Pharmacy Learning Network
PharmLaw
03/04/2026
Grace Taylor, MS, MA
Louisiana secured a $45 million settlement from CVS and its pharmacy benefit manager (PBM) affiliate following lawsuits alleging deceptive practices, misuse of patient data, and anti-competitive conduct affecting independent pharmacies.
Louisiana secured a $45 million settlement from CVS and its pharmacy benefit manager (PBM) affiliate following lawsuits alleging deceptive practices, misuse of patient data, and anti-competitive conduct affecting independent pharmacies.
Louisiana secured a $45 million...
03/04/2026
Pharmacy Learning Network
PharmLaw
02/27/2026
Grace Taylor, MS, MA
A federal judge has preliminarily approved a $5.275 million nationwide settlement resolving claims that PharMerica failed to safeguard patient data in a 2023 ransomware attack.
A federal judge has preliminarily approved a $5.275 million nationwide settlement resolving claims that PharMerica failed to safeguard patient data in a 2023 ransomware attack.
A federal judge has...
02/27/2026
Pharmacy Learning Network
News
02/26/2026
Grace Taylor, MS, MA
Slate Run Pharmaceuticals has initiated a nationwide Class III recall of eptifibatide injection after discovering a labeling error that incorrectly describes the product’s dosing instructions.
Slate Run Pharmaceuticals has initiated a nationwide Class III recall of eptifibatide injection after discovering a labeling error that incorrectly describes the product’s dosing instructions.
Slate Run Pharmaceuticals has...
02/26/2026
Pharmacy Learning Network
PharmLaw
02/25/2026
Grace Taylor, MS, MA
A Texas physician was sentenced to prison for accepting kickbacks tied to medically unnecessary compounded creams billed to the US Department of Labor’s Office of Workers’ Compensation Programs (DOL-OWCP) and private insurers.
A Texas physician was sentenced to prison for accepting kickbacks tied to medically unnecessary compounded creams billed to the US Department of Labor’s Office of Workers’ Compensation Programs (DOL-OWCP) and private insurers.
A Texas physician was sentenced...
02/25/2026
Pharmacy Learning Network
News
02/19/2026
Hannah Musick
A Class II recall for thiamine HCl 500 mg in 0.9% Sodium Chloride Injection has been issued due to a lack of sterility assurance, affecting more than 10 000 IV bags distributed nationwide.
A Class II recall for thiamine HCl 500 mg in 0.9% Sodium Chloride Injection has been issued due to a lack of sterility assurance, affecting more than 10 000 IV bags distributed nationwide.
A Class II recall for thiamine...
02/19/2026
Pharmacy Learning Network
News
02/19/2026
Hannah Musick
The US Food and Drug Administration (FDA) has issued a Class II recall for oxycodone hydrochloride tablets after reports of defective blister packaging seals, raising concerns about dose loss and controlled substance accountability.
The US Food and Drug Administration (FDA) has issued a Class II recall for oxycodone hydrochloride tablets after reports of defective blister packaging seals, raising concerns about dose loss and controlled substance accountability.
The US Food and Drug...
02/19/2026
Pharmacy Learning Network
PharmLaw
02/18/2026
Hannah Musick
Atlantic Biologicals Corporation has entered a 2-year deferred prosecution agreement after admitting its business unit sold more than 14 million opioid doses to Houston-area pill mill pharmacies, generating over $2.5 million in gross proceeds.
Atlantic Biologicals Corporation has entered a 2-year deferred prosecution agreement after admitting its business unit sold more than 14 million opioid doses to Houston-area pill mill pharmacies, generating over $2.5 million in gross proceeds.
Atlantic Biologicals Corporation...
02/18/2026
Pharmacy Learning Network

Insights

Headshot and logo for Talking Therapeutics with Douglas Jennings, PharmD
Talking Therapeutics
09/22/2022
Douglas L. Jennings, PharmD, FACC, FAHA, FCCP, FHFSA, BCPS
Dr Jennings reviews guideline recommendations and new research into the use of antibiotics in patients who are about to undergo invasive dental procedures.
Dr Jennings reviews guideline recommendations and new research into the use of antibiotics in patients who are about to undergo invasive dental procedures.
Dr Jennings reviews guideline...
09/22/2022
Pharmacy Learning Network

Interactive Features